ArriVent BioPharma, Inc. (AVBP) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 42 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026after close 40 8-K
Q2 FY2026Wed, Aug 12, 2026after close 43 8-K
Q1 FY2026Mon, May 11, 2026after close 41 8-K
Q4 FY2025Thu, Mar 5, 2026after close 64 8-K
Q3 FY2025Mon, Nov 10, 2025before open 41 8-K
Q2 FY2025Mon, Aug 11, 2025before open 42 8-K
Q1 FY2025Mon, May 12, 2025before open 42 8-K
Q4 FY2024Mon, Mar 3, 2025before open 62 8-K

What they guided beta

Q3 FY2026 "· Cash and investments of $393.2 million as of September 30, 2026 expected to fund operations to mid-2028" exhibit
Q3 FY2026 "Phase 1b dose optimization data for ARR-217 in late line colorectal cancer are expected in the first half of 2027, and ARR-217 combination data with bevacizumab as well as combination data with chemotherapy are expected in the second half of 2027." exhibit
Q3 FY2026 "· As of September 30, 2026, the Company had cash and investments of $393.2 million, which is expected to fund operations to mid-2028." exhibit
Q2 FY2026 "· Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected 2H 2026" exhibit
Q2 FY2026 "· Dosing of first patient with ARR-002, a dual-targeting MUC16/NaPi2b tetravalent ADC with initial focus in ovarian and endometrial cancers expected Q3 2026" exhibit
Q2 FY2026 "· Cash and investments of $373.1 million as of June 30, 2026 expected to fund operations into 2028" exhibit
Q2 FY2026 "Dosing of first patient with ARR-002 in a Phase 1 trial expected in the third quarter of 2026." exhibit
Q2 FY2026 "· As of June 30, 2026, the Company had cash and investments of $373.1 million, which is expected to fund operations into 2028." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AVBP
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AVBP

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AVBP earnings date badge

HTML

<a href="https://veritasdata.dev/company/AVBP/"><img src="https://veritasdata.dev/embed/AVBP.svg" alt="AVBP earnings date" width="240" height="56"></a>

Markdown

[![AVBP earnings date](https://veritasdata.dev/embed/AVBP.svg)](https://veritasdata.dev/company/AVBP/)

Script

<script async src="https://veritasdata.dev/embed/AVBP.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AVBP"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.